Galephar Pharmaceutical Research Inc.January 20, 2023

FDA 483 - Galephar Pharmaceutical Research Inc. - January 20, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Galephar Pharmaceutical Research Inc.

Record Details

Galephar Pharmaceutical Research Inc. in Humacao, PR, was inspected by the FDA, resulting in two observations. The inspection revealed failures in thoroughly reviewing unexplained discrepancies related to drug product batch yields and inadequate equipment maintenance. These issues included a lack of a preventive maintenance plan and unreported damage to product contact parts, indicating potential concerns with quality control and manufacturing practices.

Company: Galephar Pharmaceutical Research Inc.
Inspection Date: January 20, 2023
Product Type: Drugs
Office: Division of Human and Animal Food Operations - East IV

Open in Dashboard

ID · 31af354d-f774-40f1-96f0-5d6b7e534577